Saturday 17 October 2026 Export PACS’s income statement to Excel — free account

PACS Group, Inc.

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

46.91 0.84 −1.76%

Follow PACS

Alert me

Market cap: $7.6B
P/E: 27.6×
Fwd P/E: 16.8×
Dividend yield: —
F-score: 7/9
Altman Z: 2.00
Beneish M: −2.74
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.50

Total sells 84.95

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	—	1	—	1	4	5	4	5	2

Insider Ownership 71.22%

Capital & Financial Ratios $m

Market Cap 7,560.00

Revenue 5,551.04

Net Income 269.13

Free Cash Flow 456.53

Net Debt 81.64

Current Ratio 0.91

Debt/Equity 0.22

P/E ratio 27.59

Fwd P/E 16.80

P/S ratio 1.34

P/B ratio 6.65

Past 5Y EPS Growth —

This Y EPS Growth 32.37%

Next Y EPS Growth 10.69%

Next Y revenue growth 10.51%

Next 5Y EPS Growth 17.00%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	73	158	197	164
Receivables	600	717	702	724
Inventory	—	—	—	—
Other	—	—	—	—
	722	938	1,070	962

	2023	2024	2025	Q'26
Payables	141	175	192	161
ST’ Debt	17	15	4	7
Other	—	146	181	181
	457	978	1,001	1,055

Compound Annual Growth %

	10y	5y	3y
Sales	—	—	29.74%
Cash Flow	—	—	63.42%
Earnings	—	—	8.37%
Book Value	—	—	140.29%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1,420	1,428	—	—	—
’25	1,277	1,309	1,345	1,358	5,289
’24	920	936	1,026	1,208	4,090
’23	708	761	789	853	3,111
’22	—	—	—	—	2,422

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	236	136	—	—	—
’25	150	53	205	(3)	404
’24	59	35	209	65	367
’23	79	(21)	15	(10)	64
’22	—	—	—	93	93

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	215	109	—	—	—
’25	133	34	187	(54)	300
’24	48	19	195	40	302
’23	73	(31)	1	(25)	19
’22	—	—	—	70	70

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.50	0.47	—	—	—
’25	0.17	0.31	0.32	0.43	1.22
’24	0.27	(0.21)	0.10	0.25	0.38
’23	0.29	0.16	0.15	0.27	0.88
’22	—	—	—	—	1.17

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	—	—	—	12.54	7.50	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	—	—	—	43.92	40.09
People
People	Employees	—	—	—	—	—	—	—	32,433	45,680	47,455
	Revenue/emp, $m	—	—	—	—	—	0.00	0.00	0.10	0.09	0.11
Income, $m
Income, $m	Revenue	—	—	—	—	—	1,167	2,422	3,111	4,090	5,289
	Gross margin, %	—	—	—	—	—	16.06	16.54	14.37	12.41	14.75
	EBT	—	—	—	—	—	81	207	157	102	284
	EBT margin, %	—	—	—	—	—	6.98	8.55	5.06	2.48	5.38
	Net income	—	—	—	—	—	48	150	113	55	191
	Depreciation	—	—	—	—	—	8	24	32	44	59
Per share, $
Per share, $	Revenue	—	—	—	—	—	9.06	18.82	24.17	27.89	33.86
	Earnings	—	—	—	—	—	0.37	1.17	0.88	0.38	1.23
	Cash flow	—	—	—	—	—	0.45	0.72	0.49	2.50	2.59
	Capex	—	—	—	—	—	(0.96)	(0.18)	(0.35)	(0.44)	(0.67)
	Free cash flow	—	—	—	—	—	(0.52)	0.54	0.15	2.06	1.92
	Book value	—	—	—	—	—	0.00	0.53	0.79	4.88	6.10
	Shares, m	—	—	—	—	—	129	129	129	147	156
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	26.89	26.89	26.89	32.20	31.47
	P/S	—	—	—	—	—	0.89	0.89	0.89	0.47	1.13
	P/B	—	—	—	—	—	22.16	22.16	22.16	2.69	6.30
	EV/Sales	—	—	—	—	—	1.10	1.10	1.10	0.50	1.16
	EV/FCF	—	—	—	—	—	(546.96)	(546.96)	(546.96)	6.72	20.52
Cash, $m
Cash, $m	Operating cash flow	—	—	—	—	—	58	93	64	367	404
	Capex	—	—	—	—	—	(124)	(23)	(45)	(65)	(105)
	Free cash flow	—	—	—	—	—	(66)	70	19	302	300
Balance, $m
Balance, $m	Working capital	—	—	—	—	—	—	27	265	(40)	68
	Total debt	—	—	—	—	—	—	500	733	266	349
	Net debt	—	—	—	—	—	—	441	659	108	152
	Shareholders’ equity	—	—	—	—	—	—	69	102	716	952
Returns, %
Returns, %	ROA	—	—	—	—	—	0.00	12.23	3.78	1.27	3.54
	ROIC	—	—	—	—	—	0.00	28.10	17.07	9.34	17.52
	ROE	—	—	—	—	—	0.00	0.00	132.50	13.64	22.96

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
DVA DaVita Inc.	$12.1B	15.0×	13.1×	+5.17% (above 0%: growing)	+56.49% (above 0%: growing)	+49.36% (above 0%: growing)	32.70%	16.29%	Compare
FMS Fresenius Medical Care AG & Co. KGaA	$11.8B	11.5×	12.5×	+3.89% (above 0%: growing)	+6.82% (above 0%: growing)	+1.57% (above 0%: growing)	26.95%	9.58%	Compare
UHS Universal Health Services, Inc.	$11.0B	7.5×	6.1×	+8.27% (above 0%: growing)	+9.47% (above 0%: growing)	−23.78% (below 0%: shrinking)	90.87%	11.14%	Compare
ENSG The Ensign Group, Inc.	$10.4B	26.9×	24.1×	+17.33% (above 0%: growing)	+16.22% (above 0%: growing)	+12.24% (above 0%: growing)	16.65%	8.50%	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%	Compare
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
LFST LifeStance Health Group, Inc.	$4.7B	88.3×	58.5×	+26.08% (above 0%: growing)	n/m	+55.22% (above 0%: growing)	35.15%	7.04%	Compare
OPCH Option Care Health, Inc.	$4.7B	23.5×	14.1×	+1.86% (above 0%: growing)	+12.90% (above 0%: growing)	+112.36% (above 0%: growing)	18.53%	5.90%	Compare
Median of peers	$8.6B	24.2×	15.6×	+8.54%	+16.22%	+30.80%	32.20%	10.36%

All 55 Medical Care Facilities stocks →

PACS Group, Inc. (PACS) key facts

Strength: PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
PACS Group, Inc. (PACS) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, PACS traded at $46.91, a market capitalization of $7.6 billion.
Return on equity was 23.0% and debt-to-equity 0.22.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.00 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.